Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susan Pav is active.

Publication


Featured researches published by Susan Pav.


Photochemistry and Photobiology | 1995

INACTIVATION OF CELL SURFACE RECEPTORS BY PHEOPHORBIDE a, A GREEN PIGMENT ISOLATED FROM Psychotria acuminata

Jan A. Glinski; Eva David; Thomas C. Warren; Gordon Hansen; Scott F. Leonard; Phillip Pitner; Susan Pav; Rosita Arvigo; Michael J. Balick; Eligio Panti; Peter M. Grob

Abstract— The inhibition of cytokine and monoclonal antibody binding to cell surfaces caused by an extract of Psychotria acuminata, a medicinal plant used in the traditional medicine of the people of Belize (Central America), was attributed to the presence of pheophorbide a and pyropheophorbide a Since the binding of tumor necrosis factor‐alpha, interleukin‐8, complement factor 5a as well as epidermal growth factor to target cells was dramatically reduced, the inhibition was not receptor or cytokine specific. In addition, the respective binding of radiolabeled monoclonal antibodies CL203 and R15.7 to the cell surface antigens intracellular cell adhesion molecule‐1 and lymphocyte function‐associated antigen‐1 ß‐chain was decreased by pretreatment of cells with pheophorbide a as well. In all cases, the inhibition by pheophorbides was dependent on the simultaneous presence of light, indicating causative involvement of a photodynamic process. These observations are not unique to pheophorbides and can be extended to porphyrins as well as to other photodynamic agents. Cytotoxicity resulting from photodynamic therapy (PDT) has been documented by many studies. Our investigations suggest that the inactivation of cell surface receptors contributes not only to the antitumor effect of PDT but also to the systemic immunosuppression, a serious side effect of PDT.


Journal of Enzyme Inhibition | 1997

Inhibition of Dipeptidyl Peptidase iv (CD26) by Peptide Boronic Acid Dipeptides

Christopher Pargellis; Campbell Sj; Susan Pav; Edward T. Graham; Pitner Tp

Peptide boronic acid dipeptide compounds were analyzed for their ability to inhibit recombinant human dipeptidylpeptidase IV (CD26, DPPIV). Rate constants for the peptide boronates are difficult to obtain because the active boronic acid dipeptide exists in equilibrium with a cyclic inactive species in aqueous solution. Rate constants were determined for the inhibition of DPPIV using several peptide boronates at different pH values. Val-boroPro forms the most tightly bound complex with DPPIV; the first order half life for dissociation of the inactive enzyme-inhibitor complex at 23 degrees C is approximately 27 days.


Nature Structural & Molecular Biology | 1997

A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket.

Liang Tong; Susan Pav; Della White; Sheri Rogers; Kathy Crane; Charles L. Cywin; Maryanne L. Brown; Christopher Pargellis


Journal of the American Chemical Society | 2001

Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies: Evidence for the Allosteric Inhibition of a Protein−Protein Interaction

Kathleen Last-Barney; Walter Davidson; Mario G. Cardozo; Leah L. Frye; Christine A. Grygon; Jerry L. Hopkins; Deborah D. Jeanfavre; Susan Pav; Chungeng Qian; James M. Stevenson; Liang Tong; Renee M. Zindell; Terence A. Kelly


Journal of Medicinal Chemistry | 2002

Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitors

Yancey David Ward; David S. Thomson; Leah L. Frye; Charles L. Cywin; Tina Morwick; Michel J. Emmanuel; Renee M. Zindell; Daniel W. McNeil; Younes Bekkali; Marc Giradot; Matt Hrapchak; Molly Deturi; Kathy Crane; Della White; Susan Pav; Yong Wang; Ming-Hong Hao; Christine A. Grygon; Mark E. Labadia; Dorothy M. Freeman; Walter Davidson; Jerry L. Hopkins; Maryanne L. Brown; Denice M. Spero


Proceedings of the National Academy of Sciences of the United States of America | 1993

Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures

Liang Tong; Susan Pav; Christopher Pargellis; Florence Dô; Daniel Lamarre; Paul C. Anderson


Journal of Medicinal Chemistry | 2003

Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase.

Daniel R. Goldberg; Tanja Butz; Mario G. Cardozo; Robert J. Eckner; Abdelhakim Hammach; Jessica Huang; Scott Jakes; Suresh R. Kapadia; Mohammed A. Kashem; Susan Lukas; Tina Morwick; Maret Panzenbeck; Usha R. Patel; Susan Pav; Gregory W. Peet; Jeffrey D. Peterson; Anthony S. Prokopowicz; Roger J. Snow; Rosemarie Sellati; Hidenori Takahashi; Jonathan Tan; Matt Aaron Tschantz; Xiao-Jun Wang; Yong Wang; John P. Wolak; Pla Xiong; Neil Moss


Journal of Medicinal Chemistry | 2000

2‘,6‘-Dimethylphenoxyacetyl: A New Achiral High Affinity P3-P2 Ligand for Peptidomimetic-Based HIV Protease Inhibitors

Pierre L. Beaulieu; Paul C. Anderson; Dale R. Cameron; Gilbert Croteau; Vida Gorys; Chantal Grand-Maitre; Daniel Lamarre; Francine Liard; William Paris; Louis Plamondon; Francois Soucy; Diane Thibeault; Dominik Wernic; Christiane Yoakim; Susan Pav; Liang Tong


Journal of Medicinal Chemistry | 1997

Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.

Pierre L. Beaulieu; Dominik Wernic; A Abraham; Paul C. Anderson; T Bogri; Y Bousquet; G Croteau; I Guse; Daniel Lamarre; Francine Liard; William Paris; Diane Thibeault; Susan Pav; Liang Tong


Structure | 1995

Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere

Liang Tong; Susan Pav; Suet Mui; Daniel Lamarre; Christiane Yoakim; Pierre L. Beaulieu; Paul C. Anderson

Collaboration


Dive into the Susan Pav's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Grace Jung

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge